cgp 35348 has been researched along with Amnesia-Memory Loss in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, PA; Bernasconi, R; Diel, PJ; Froestl, W; Hall, RG; Maier, L; Melillo, V; Mickel, SJ; Strub, D; von Sprecher, G | 1 |
Bianchi, M; Panerai, AE | 1 |
2 other study(ies) available for cgp 35348 and Amnesia-Memory Loss
Article | Year |
---|---|
Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists.
Topics: Administration, Oral; Amnesia; Animals; Cerebral Cortex; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Hippocampus; In Vitro Techniques; Learning; Long-Term Potentiation; Magnetic Resonance Spectroscopy; Phosphinic Acids; Protein Binding; Radioligand Assay; Rats; Receptors, GABA-B; Structure-Activity Relationship | 1995 |
Reversal of scopolamine-induced amnesia by the GABAB receptor antagonist CGP 35348 in the mouse.
Topics: Amnesia; Animals; Avoidance Learning; Cognition; GABA-A Receptor Antagonists; Male; Mice; Mice, Inbred Strains; Organophosphorus Compounds; Scopolamine | 1993 |